Tissue Genesis, Inc.is organized around research into adipose-derived cell therapy and regenerative medicine solutions. The company focuses on clinical validation of the use of patients? own adipose- (fat) derived stem cells to treat conditions, such as heart diseases, vascular diseases, orthopedic and spine injuries and diseases, soft tissue and reconstructive repairs, and pelvic health disorders. The firm's products include Icellator Cell Isolation System that isolates various regenerative stem cells comprising stromal vascular fractions; and Adipase, a solution for application with adipose tissues. Also addressing the coating of implants, such as vascular grafts, stents, and delivery of cells in a wound dressing, the company has developed various therapies, including orthopedic applications for joint and cartilage repairs, rotator cuff injuries, aesthetics and reconstruction, pelvic health disorders, and wound healing. Its regenerative medicine solutions comprise adult stem cells and adipose-derived stem cells.
